Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men

Perspectives of PrEP users and high-risk PrEP naïve men

S. Wade Taylor, Kenneth H. Mayer, Steven M. Elsesser, Matthew J. Mimiaga, Conall O'Cleirigh, Steven Safren

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Existing trials of antiretroviral (ARV) medication as chemoprophylaxis against HIV reveal that the degree of protection is primarily dependent on product adherence. However, there is a lack of data on targets for behavioral interventions to improve adherence to ARV as prevention. Information from individuals who have used ARV as pre-exposure prophylaxis (PrEP) can inform behavioral intervention development. Thirty-nine HIV-uninfected MSM at high risk for HIV acquisition participated in one of four semi-structured focus groups. Two of the focus groups consisted of MSM who had been prescribed and used PrEP in the context of a clinical trial; the other two consisted of high-risk MSM who had not previously used PrEP. An in-depth, within-case/across-case content analysis resulted in six descriptive themes potentially salient for a PrEP adherence behavioral intervention: (1) motivations to use PrEP, (2) barriers to PrEP use, (3) facilitators to PrEP use, (4) sexual decision-making in the context of PrEP, (5) prospective PrEP education content, and, (6) perceived effective characteristics of PrEP delivery personnel. Addressing these themes in behavioral interventions in the context of prescribing PrEP may result in the optimal "packaging" public health programs that implement PrEP for high-risk MSM.

Original languageEnglish (US)
Pages (from-to)871-879
Number of pages9
JournalAIDS and Behavior
Volume18
Issue number5
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Counseling
HIV
Focus Groups
Pre-Exposure Prophylaxis
Chemoprevention
Product Packaging
Motivation
Decision Making
Public Health
Clinical Trials
Education

Keywords

  • Adherence
  • Antiretroviral therapy for prevention
  • ART
  • HIV prevention
  • MSM
  • Pre-exposure prophylaxis (PrEP)

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases
  • Social Psychology
  • Medicine(all)

Cite this

Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men : Perspectives of PrEP users and high-risk PrEP naïve men. / Wade Taylor, S.; Mayer, Kenneth H.; Elsesser, Steven M.; Mimiaga, Matthew J.; O'Cleirigh, Conall; Safren, Steven.

In: AIDS and Behavior, Vol. 18, No. 5, 2014, p. 871-879.

Research output: Contribution to journalArticle

Wade Taylor, S. ; Mayer, Kenneth H. ; Elsesser, Steven M. ; Mimiaga, Matthew J. ; O'Cleirigh, Conall ; Safren, Steven. / Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men : Perspectives of PrEP users and high-risk PrEP naïve men. In: AIDS and Behavior. 2014 ; Vol. 18, No. 5. pp. 871-879.
@article{e93cfa3427ef4b97b3bbed7b46701abe,
title = "Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: Perspectives of PrEP users and high-risk PrEP na{\"i}ve men",
abstract = "Existing trials of antiretroviral (ARV) medication as chemoprophylaxis against HIV reveal that the degree of protection is primarily dependent on product adherence. However, there is a lack of data on targets for behavioral interventions to improve adherence to ARV as prevention. Information from individuals who have used ARV as pre-exposure prophylaxis (PrEP) can inform behavioral intervention development. Thirty-nine HIV-uninfected MSM at high risk for HIV acquisition participated in one of four semi-structured focus groups. Two of the focus groups consisted of MSM who had been prescribed and used PrEP in the context of a clinical trial; the other two consisted of high-risk MSM who had not previously used PrEP. An in-depth, within-case/across-case content analysis resulted in six descriptive themes potentially salient for a PrEP adherence behavioral intervention: (1) motivations to use PrEP, (2) barriers to PrEP use, (3) facilitators to PrEP use, (4) sexual decision-making in the context of PrEP, (5) prospective PrEP education content, and, (6) perceived effective characteristics of PrEP delivery personnel. Addressing these themes in behavioral interventions in the context of prescribing PrEP may result in the optimal {"}packaging{"} public health programs that implement PrEP for high-risk MSM.",
keywords = "Adherence, Antiretroviral therapy for prevention, ART, HIV prevention, MSM, Pre-exposure prophylaxis (PrEP)",
author = "{Wade Taylor}, S. and Mayer, {Kenneth H.} and Elsesser, {Steven M.} and Mimiaga, {Matthew J.} and Conall O'Cleirigh and Steven Safren",
year = "2014",
doi = "10.1007/s10461-013-0617-7",
language = "English (US)",
volume = "18",
pages = "871--879",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men

T2 - Perspectives of PrEP users and high-risk PrEP naïve men

AU - Wade Taylor, S.

AU - Mayer, Kenneth H.

AU - Elsesser, Steven M.

AU - Mimiaga, Matthew J.

AU - O'Cleirigh, Conall

AU - Safren, Steven

PY - 2014

Y1 - 2014

N2 - Existing trials of antiretroviral (ARV) medication as chemoprophylaxis against HIV reveal that the degree of protection is primarily dependent on product adherence. However, there is a lack of data on targets for behavioral interventions to improve adherence to ARV as prevention. Information from individuals who have used ARV as pre-exposure prophylaxis (PrEP) can inform behavioral intervention development. Thirty-nine HIV-uninfected MSM at high risk for HIV acquisition participated in one of four semi-structured focus groups. Two of the focus groups consisted of MSM who had been prescribed and used PrEP in the context of a clinical trial; the other two consisted of high-risk MSM who had not previously used PrEP. An in-depth, within-case/across-case content analysis resulted in six descriptive themes potentially salient for a PrEP adherence behavioral intervention: (1) motivations to use PrEP, (2) barriers to PrEP use, (3) facilitators to PrEP use, (4) sexual decision-making in the context of PrEP, (5) prospective PrEP education content, and, (6) perceived effective characteristics of PrEP delivery personnel. Addressing these themes in behavioral interventions in the context of prescribing PrEP may result in the optimal "packaging" public health programs that implement PrEP for high-risk MSM.

AB - Existing trials of antiretroviral (ARV) medication as chemoprophylaxis against HIV reveal that the degree of protection is primarily dependent on product adherence. However, there is a lack of data on targets for behavioral interventions to improve adherence to ARV as prevention. Information from individuals who have used ARV as pre-exposure prophylaxis (PrEP) can inform behavioral intervention development. Thirty-nine HIV-uninfected MSM at high risk for HIV acquisition participated in one of four semi-structured focus groups. Two of the focus groups consisted of MSM who had been prescribed and used PrEP in the context of a clinical trial; the other two consisted of high-risk MSM who had not previously used PrEP. An in-depth, within-case/across-case content analysis resulted in six descriptive themes potentially salient for a PrEP adherence behavioral intervention: (1) motivations to use PrEP, (2) barriers to PrEP use, (3) facilitators to PrEP use, (4) sexual decision-making in the context of PrEP, (5) prospective PrEP education content, and, (6) perceived effective characteristics of PrEP delivery personnel. Addressing these themes in behavioral interventions in the context of prescribing PrEP may result in the optimal "packaging" public health programs that implement PrEP for high-risk MSM.

KW - Adherence

KW - Antiretroviral therapy for prevention

KW - ART

KW - HIV prevention

KW - MSM

KW - Pre-exposure prophylaxis (PrEP)

UR - http://www.scopus.com/inward/record.url?scp=84899584009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899584009&partnerID=8YFLogxK

U2 - 10.1007/s10461-013-0617-7

DO - 10.1007/s10461-013-0617-7

M3 - Article

VL - 18

SP - 871

EP - 879

JO - AIDS and Behavior

JF - AIDS and Behavior

SN - 1090-7165

IS - 5

ER -